# Transdermal Diagnostics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/transdermal-diagnostics

- Industry: Medical Devices & Equipment
- Headquarters: Bath, UK
- Website: www.transdermal-diagnostics.com
- Total disclosed funding: $0.9M
- Latest round: Seed (Jul 7, 2022)
- Investors on record: 5

## About

Based in Bath, UK, and founded in 2021, Transdermal Diagnostics Ltd, a MedTech spin-out, operates as a developer of non-invasive wearable patches, intended to track biomarkers in humans. The company was founded by Luca Lipani (CEO, as of 2022), Adelina Ilie (CSO), and Richard Guy (Director), and in September 2022, Transdermal Diagnostics Ltd received GBP 300,000 of grant funding from Innovate UK.

The company develops and provides wearable, disposable patches, that are capable of monitoring human blood glucose levels in real-time. The firm’s product utilizes a proprietary sensing architecture, where biological substances are drawn out through the user’s hair follicles, and biomarker information is transmitted to a mobile application, helping patients suffering from type 1 diabetes, type 2 diabetes, and prediabetes to stay vigilant about their sugar levels and thereby prevent disease progression as well as further complications.

The company will use the September 2022 funding to advance its technology and support its engineering team and prepare for clinical trials.

## Funding rounds

- Seed, Jul 7, 2022, $0.9M — Qubis, Pioneer Fund, Bristol Private Equity Club, Science Angel Syndicate, Immetric

## Investors

- Qubis (https://capitalatlas.ai/funds/qubis) — Seed
- Pioneer Fund (https://capitalatlas.ai/funds/pioneer-fund) — Seed
- Bristol Private Equity Club (https://capitalatlas.ai/funds/bristol-private-equity-club) — Seed
- Science Angel Syndicate (https://capitalatlas.ai/funds/science-angel-syndicate) — Seed
- Immetric (https://capitalatlas.ai/funds/immetric) — Seed